Zhang Yu-Min, Zhang Zhen-Ye, Wang Ru-Xing
Department of Cardiology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Front Physiol. 2020 Jul 31;11:956. doi: 10.3389/fphys.2020.00956. eCollection 2020.
Quercetin has attracted more attention in recent years due to its protective role against ischemia/reperfusion injury. Quercetin can alleviate oxidative stress injury through the inhibition of NADPH oxidase and xanthine oxidase, blockage of the Fenton reaction, and scavenging of reactive oxygen species. Quercetin can also exert anti-inflammatory and anti-apoptotic effects by reducing the response to inflammatory factors and inhibiting cell apoptosis. Moreover, it can induce vasodilation effects through the inhibition of endothelin-1 receptors, the enhancement of NO stimulation and the activation of the large-conductance calcium-activated potassium channels. Finally, Quercetin can also antagonize the calcium overload. These multifaceted activities of Quercetin make it a potential therapeutic alternative for the treatment of ischemia/reperfusion injury.
近年来,槲皮素因其对缺血/再灌注损伤的保护作用而备受关注。槲皮素可通过抑制NADPH氧化酶和黄嘌呤氧化酶、阻断芬顿反应以及清除活性氧来减轻氧化应激损伤。槲皮素还可通过降低对炎症因子的反应并抑制细胞凋亡发挥抗炎和抗凋亡作用。此外,它可通过抑制内皮素-1受体、增强一氧化氮刺激以及激活大电导钙激活钾通道来诱导血管舒张效应。最后,槲皮素还可拮抗钙超载。槲皮素的这些多方面活性使其成为治疗缺血/再灌注损伤的潜在治疗选择。